Skip to main content

Advertisement

Log in

Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies

  • IM-Point of view
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data Availability

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

References

  1. Klijn CJ, Paciaroni M, Berge E, Korompoki E, Korv J, Lal A, Putaala J, Werring DJ (2019) Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transiet ischemic attack and non-valvular atrial fibrillation: a European Stroke Organization guideline. Eur Stroke J 4(3):198–223

    Article  PubMed  PubMed Central  Google Scholar 

  2. Grymonprez M, Simoens C, Steurbaut S, De Backer TL, Lahousse L (2022) Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis. Europace 24(6):887–898. https://doi.org/10.1093/europace/euab303

    Article  PubMed  Google Scholar 

  3. Polymeris AA, Meinel TR, Oehler H, Hölscher K, Zietz A, Scheitz JF, Nolte CH, Stretz C, Yaghi S, Stoll S, Wang R, Häusler KG, Hellwig S, Klammer MG, Litmeier S, Guerrero CRL, Moeini-Naghani I, Michel P, Strambo D, Salerno A, Bianco G, Cereda C, Uphaus T, Gröschel K, Katan M, Wegener S, Peters N, Engelter ST, Lyrer PA, Bonati LH, Grunder L, Ringleb PA, Fischer U, Kallmünzer B, Purrucker JC, Seiffge DJ (2022) Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial firillation. J Neurol Neurosurg Psychiatry 93(6):588–598

    Article  PubMed  Google Scholar 

  4. Paciaroni M, Caso V, Agnelli G, Mosconi MG, Giustozzi M, Seiffge DJ, Engelter ST, Lyrer P, Polymeris AA, Kriemler L, Zietz A, Putaala J, Strbian D, Tomppo L, Michel P, Strambo D, Salerno A, Remillard S, Buehrer M, Bavaud O, Vanacker P, Zuurbier S, Yperzeele L, Loos CMJ, Cappellari M, Emiliani A, Zedde M, Abdul-Rahim A, Dawson J, Cronshaw R, Schirinzi E, Del Sette M, Stretz C, Kala N, Reznik M, Schomer A, Mac Grory B, Jayaraman M, McTaggart R, Yaghi S, Furie KL, Masotti L, Grifoni E, Toni D, Risitano A, Falcou A, Petraglia L, Lotti EM, Padroni M, Pavolucci L, Lochner P, Silvestrelli G, Ciccone A, Alberti A, Venti M, Traballi L, Urbini C, Kargiotis O, Rocco A, Diomedi M, Marcheselli S, Caliandro P, Zauli A, Reale G, Antonenko K, Rota E, Tassinari T, Saia V, Palmerini F, Aridon P, Arnao V, Monaco S, Cottone S, Baldi A, D’Amore C, Ageno W, Pegoraro S, Ntaios G, Sagris D, Giannopoulos S, Kosmidou M, Ntais E, Romoli M, Pantoni L, Rosa S, Bertora P, Chiti A, Canavero I, Saggese CE, Plocco M, Giorli E, Palaiodimou L, Bakola E, Tsivgoulis G, Bandini F, Gasparro A, Terruso A, Mannino M, Pezzini A, Ornello R, Sacco S, Popovic N, Scoditti U, Genovese A, Denti L, Flomin Y, Mancuso M, Ferrari E, Caselli MC, Ulivi L, Giannini N, De Marchis GM (2022) Recurrent ischemic stroke and bleeding in patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin k antagonist oral anticoagulants: the RENO-EXTEND study. Stroke 53(8):2620–2627

    Article  CAS  PubMed  Google Scholar 

  5. Tiili P, Leventis I, Kinnunen J, Svedjebäck I, Lehto M, Karagkiozi E, Sagris D, Ntaios G, Putaala J (2021) Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation. Ann Med 53(1):1613–1620

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Vanassche T, Potpara T, Camm AJ, Heidbüchel H (2021) External reviewers 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace 23(10):1612–1676. https://doi.org/10.1093/europace/euab065

    Article  PubMed  Google Scholar 

  7. Fantoni C, Bertù L, Galliazzo S, Pola R, Pomero F, Porfidia A, Porreca E, Valeriani E, Ageno W (2021) Follow-up management of patients receiving direct oral anticoagulants. Intern Emerg Med 16(3):571–580. https://doi.org/10.1007/s11739-020-02433-w

    Article  PubMed  Google Scholar 

  8. Li A, Li MK, Crowther M, Vazquez SR (2020) Drug–drug interactions with direct oral anticoagulants associated with adverse events in the real world: a systematic review. Thromb Res 194:240–245

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Stretz C, Wu TY, Wilson D, Seiffge DJ, Smith EE, Gurol ME, Yaghi S (2021) Ischaemic stroke in anticoagulated patients with atrial fibrillation. J Neurol Neurosurg Psychiatry 92(11):1164–1172

    Article  PubMed  Google Scholar 

  10. Paciaroni M, Agnelli G, Caso V, Silvestrelli G, Seiffge DJ, Engelter S, De Marchis GM, Polymeris A, Zedde ML, Yaghi S, Michel P, Eskandari A, Antonenko K, Sohn SI, Cappellari M, Tassinari T, Tassi R, Masotti L, Katsanos AH, Giannopoulos S, Acciarresi M, Alberti A, Venti M, Mosconi MG, Vedovati MC, Pierini P, Giustozzi M, Lotti EM, Ntaios G, Kargiotis O, Monaco S, Lochner P, Bandini F, Liantinioti C, Palaiodimou L, Abdul-Rahim AH, Lees K, Mancuso M, Pantoni L, Rosa S, Bertora P, Galliazzo S, Ageno W, Toso E, Angelini F, Chiti A, Orlandi G, Denti L, Flomin Y, Marcheselli S, Mumoli N, Rimoldi A, Verrengia E, Schirinzi E, Del Sette M, Papamichalis P, Komnos A, Popovic N, Zarkov M, Rocco A, Diomedi M, Giorli E, Ciccone A, Mac Grory BC, Furie KL, Bonetti B, Saia V, Guideri F, Acampa M, Martini G, Grifoni E, Padroni M, Karagkiozi E, Perlepe K, Makaritsis K, Mannino M, Maccarrone M, Ulivi L, Giannini N, Ferrari E, Pezzini A, Doronin B, Volodina V, Baldi A, D’Amore C, Deleu D, Corea F, Putaala J, Santalucia P, Nardi K, Risitano A, Toni D, Tsivgoulis G (2019) Causes and risk factors of cerebral ischemic events in patients with atrial fibrillation treated with non-vitamin k antagonist oral anticoagulants for stroke prevention. Stroke 50(8):2168–2174

    Article  CAS  PubMed  Google Scholar 

  11. Rubboli A, Fresco C, Paciaroni M, Rocca B, Pecora D, Enea I, Cuccia C, Patti G (2021) How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group. J Cardiovasc Med (Hagerstown) 22(11):924–928. https://doi.org/10.2459/JCM.0000000000001204

    Article  PubMed  Google Scholar 

  12. Vedovati MC, Giustozzi M, Paciaroni M (2021) Patients with atrial fibrillation receiving NOACs: the boundary between appropriate and inappropriate dose. Eur J Intern Med 88:25–27

    Article  PubMed  Google Scholar 

  13. Paciaroni M, Agnelli G, Giustozzi M, Caso V, Toso E, Angelini F, Canavero I, Micieli G, Antonenko K, Rocco A, Diomedi M, Katsanos AH, Shoamanesh A, Giannopoulos S, Ageno W, Pegoraro S, Putaala J, Strbian D, Sallinen H, Mac Grory BC, Furie KL, Stretz C, Reznik ME, Alberti A, Venti M, Mosconi MG, Vedovati MC, Franco L, Zepponi G, Romoli M, Zini A, Brancaleoni L, Riva L, Silvestrelli G, Ciccone A, Zedde ML, Giorli E, Kosmidou M, Ntais E, Palaiodimou L, Halvatsiotis P, Tassinari T, Saia V, Ornello R, Sacco S, Bandini F, Mancuso M, Orlandi G, Ferrari E, Pezzini A, Poli L, Cappellari M, Forlivesi S, Rigatelli A, Yaghi S, Scher E, Frontera JA, Masotti L, Grifoni E, Caliandro P, Zauli A, Reale G, Marcheselli S, Gasparro A, Terruso V, Arnao V, Aridon P, Abdul-Rahim AH, Dawson J, Saggese CE, Palmerini F, Doronin B, Volodina V, Toni D, Risitano A, Schirinzi E, Del Sette M, Lochner P, Monaco S, Mannino M, Tassi R, Guideri F, Acampa M, Martini G, Lotti EM, Padroni M, Pantoni L, Rosa S, Bertora P, Ntaios G, Sagris D, Baldi A, D’Amore C, Mumoli N, Porta C, Denti L, Chiti A, Corea F, Acciarresi M, Flomin Y, Popovic N, Tsivgoulis G (2021) Risk factors for intracerebral hemorrhage in patients with atrial fibrillation on non-vitamin k antagonist oral anticoagulants for stroke prevention. Stroke 52(4):1450–1454

    Article  CAS  PubMed  Google Scholar 

  14. Mosconi MG, Maraziti G, Paciaroni M, Giustozzi M, Vedovati MC, Bogliari G, Urbini C, Traballi L, Caso V (2022) Effects of direct oral anticoagulants’ nonrecommended dose in atrial fibrillation: a meta-analysis. Eur Neurol 13:1–12

    Google Scholar 

  15. Yaghi S, Henninger N, Giles JA, Leon Guerrero C, Mistry E, Liberman AL, Asad D, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Furie KL, Keyrouz SG, Nouh A, de Havenon A, Khan M, Smith EE, Gurol ME (2021) Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study. J Neurol Neurosurg Psychiatry 92(10):1062–1067

    Article  PubMed  Google Scholar 

  16. Seiffge DJ, De Marchis GM, Koga M, Paciaroni M, Wilson D, Cappellari M, Macha K, Tsivgoulis G, Ambler G, Arihiro S, Bonati LH, Bonetti B, Kallmünzer B, Muir KW, BoviP GH, Inoue M, Schwab S, Yaghi S, Brown MM, Lyrer P, Takagi M, Acciarresi M, Jager HR, Polymeris AA, Toyoda K, Venti M, Traenka C, Yamagami H, Alberti A, Yoshimura S, Caso V, Engelter ST, Werring DJ, RAF, RAF-DOAC, CROMIS-2, SAMURAI, NOACISP, Erlangen and Verona registry collaborators (2020) Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. Ann Neurol 87(5):677–687

    Article  PubMed  PubMed Central  Google Scholar 

  17. Testa S, Paoletti O, Legnani C, Dellanoce C, Antonucci E, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G (2018) Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants. J Thromb Haemost 16(5):842–848

    Article  CAS  PubMed  Google Scholar 

  18. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498

    Article  PubMed  Google Scholar 

  19. Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY (2014) Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 64(1):1–12

    Article  PubMed  Google Scholar 

  20. Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D, PROTECT AF Steering Committee and Investigators (2014) Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 312(19):1988–1998

    Article  PubMed  Google Scholar 

  21. Masjuan J, Salido L, DeFelipe A, Hernández-Antolín R, Fernández-Golfín C, Cruz-Culebras A, Matute C, Vera R, Pérez-Torre P, Zamorano JL (2019) Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke. Eur J Neurol 26(5):816–820

    Article  CAS  PubMed  Google Scholar 

  22. Galloo X, Carmeliet T, Prihadi EA, Lochy S, Scott B, Verheye S, Schoors D, Vermeersch P (2022) Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience. Acta Clin Belg 77(2):255–260

    Article  CAS  PubMed  Google Scholar 

  23. Freixa X, Cruz-González I, Regueiro A, Nombela-Franco L, Estévez-Loureiro R, Ruiz-Salmerón R, Bethencourt A, Gutiérrez-García H, Fernández-Díaz JA, Moreno-Samos JC, Jiménez-Quevedo P, Martin-Yuste V, Arnold R, Millan X, Asmarats L, Ronquillo M, Agudelo-Montañez VH, López-Mínguez JR, Goicolea J, de Pérez PA, Arzamendi D (2019) Left atrial appendage occlusion as adjunctive therapy to anticoagulation for stroke recurrence. J Invasive Cardiol 31(8):212–216

    PubMed  Google Scholar 

  24. Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR, PACIFIC-AF Investigators (2022) Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. Lancet 399(10333):1383–1390. https://doi.org/10.1016/S0140-6736(22)00456-1

    Article  CAS  PubMed  Google Scholar 

  25. De Potter T, Yodfat O, Shinar G, Neta A, Reddy VY, Neuzil P, Veltkamp R, Connolly SJ (2020) Permanent bilateral carotid filters for stroke prevention in atrial fibrillation. Curr Cardiol Rep 22(11):144. https://doi.org/10.1007/s11886-020-01388-w

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ilaria Leone De Magistris.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Magistris, I.L., Paciaroni, M. Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies. Intern Emerg Med 18, 963–967 (2023). https://doi.org/10.1007/s11739-023-03266-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-023-03266-z

Keywords

Navigation